Troubling Tenosynovitis: When a Serious Sign Persists

Am J Med. 2021 Sep;134(9):1107-1109. doi: 10.1016/j.amjmed.2021.02.033. Epub 2021 Apr 1.

Authors

Griffin Reed¹, Jesse Dabit², Shreyasee Amin³

Affiliations

¹ Department of Internal Medicine, Rhode Island Hospital, Providence.
² Division of Rheumatology, Mayo Clinic, Rochester, Minn.
³ Division of Rheumatology, Mayo Clinic, Rochester, Minn. Electronic address: Amin.Shreyasee@mayo.edu.

PMID: 33812863
DOI: 10.1016/j.amjmed.2021.02.033

No abstract available

Publication types

Case Reports

MeSH terms

Adult
Anti-Bacterial Agents / administration & dosage
Arthritis* / diagnosis
Arthritis* / immunology
Arthritis* / microbiology
Arthritis* / physiopathology
Autoantibodies / blood*
Ceftriaxone / administration & dosage*
Diagnosis, Differential
Female
Gonorrhea* / complications
Gonorrhea* / diagnosis
Gonorrhea* / physiopathology
Gonorrhea* / therapy
Hereditary Complement Deficiency Diseases / etiology
Hereditary Complement Deficiency Diseases / immunology
Humans
Immunologic Tests / methods
Lupus Erythematosus, Systemic* / complications
Lupus Erythematosus, Systemic* / immunology
Lupus Erythematosus, Systemic* / physiopathology
Lupus Erythematosus, Systemic* / therapy
Lupus Nephritis / therapy
Neisseria gonorrhoeae / isolation & purification*
Tenosynovitis* / diagnosis
Tenosynovitis* / etiology
Tenosynovitis* / microbiology
Treatment Outcome

Substances

Anti-Bacterial Agents
Autoantibodies
Ceftriaxone